Abstract
The aim of this study was to explore whether history of meconium ileus (MI) at birth in children and adolescents with cystic fibrosis (CF) adversely affects body composition and lung function in later life. Data of children and adolescents with CF who underwent spirometry and DXA as part of their routine care were analyzed. Associations between MI (explanatory variable) and areal bone mineral density (total body less head—TBLH aBMD), lean tissue mass (LTM), and fat mass (FM) (outcomes) were assessed using general linear models. Potential relationships of TBLH aBMD, LTM, and FM with FEV1 (additional outcome) were also explored. One hundred and one subjects with CF (mean age 14 ± 3 years) were included, 19 (18.8%) of whom had history of MI. Negative associations were demonstrated between history of MI and FEV1 (P = 0.04), TBLH aBMD (P = 0.03), and FM (P < 0.01) but not between history of MI and LTM (P = 0.07) after adjustment for other variables. Lung function was positively associated with TBLH aBMD (P < 0.01) and LTM (P = 0.02) but not with FM (P = 0.20).
Conclusion: Among children and adolescents with CF, those with history of MI have lower bone mineral density, FM, and lung function.
What is Known: • Among children and adolescents with cystic fibrosis, those with history of meconium ileus in the neonatal period are at risk of having lower body mass index percentile and FEV 1 percent predicted. |
What is New: • Children and adolescents with cystic fibrosis and history of meconium ileus have decreased bone mineral density and fat mass compared to patients without such history. • Lower lung function in children with MI coexists with suboptimal bone mineral density. |
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CF:
-
Cystic fibrosis
- CFRD:
-
CF-related diabetes mellitus
- DXA:
-
Dual-energy X-ray absorptiometry
- FM:
-
Fat mass
- LTM:
-
Lean tissue mass
- TBLH aBMD:
-
Total body less head areal bone mineral density
References
Shepherd RW, Holt TL, Thomas BJ, Kay L, Isles A, Francis PJ, Ward LC (1986) Nutritional rehabilitation in cystic fibrosis: controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease. J Pediatr 109:788–794
Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H, Clinical Practice Guidelines on Growth and Nutrition Subcommittee; Ad Hoc Working Group (2008) Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 108:832–839
Pedreira CC, Robert RG, Dalton V, Oliver MR, Carlin JB, Robinson P, Cameron FJ (2005) Association of body composition and lung function in children with cystic fibrosis. Pediatr Pulmonol 39:276–280
Cystic Fibrosis Foundation Patient Registry (2014) 2013 annual data report to the center directors. Bethesda, Maryland
Buntain HM, Schluter PJ, Bell SC, Greer RM, Wong JC, Batch J, Lewindon P, Wainwright CE (2006) Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax 61:146–154
Sheikh S, Zemel BS, Stallings VA, Rubenstein RC, Kelly A (2014) Body composition and pulmonary function in cystic fibrosis. Front Pediatr 2:33
Bianchi ML, Romano G, Saraifoger S, Costantini D, Limonta C, Colombo C (2006) BMD and body composition in children and young patients affected by cystic fibrosis. J Bone Miner Res 21:388–396
Williams JE, Wells JC, Benden C, Jaffe A, Suri R, Wilson CM, Fewtrell MS (2010) Body composition assessed by the 4-component model and association with lung function in 6-12-y-old children with cystic fibrosis. Am J Clin Nutr 92:1332–1343
Evans AK, Fitzgerald DA, McKay KO (2001) The impact of meconium ileus on the clinical course of children with cystic fibrosis. Eur Respir J 18:784–789
Efrati O, Nir J, Fraser D, Cohen-Cymberknoh M, Shoseyov D, Vilozni D, Modan-Moses D, Levy R, Szeinberg A, Kerem E, Rivlin J (2010) Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli Multicenter Study. J Pediatr Gastroenterol Nutr 50:173–178
Lai HC, Kosorok MR, Laxova A, Davis LA, Fitz Simmon SC, Farrell PM (2000) Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening. Pediatrics 105:53–61
Dupuis A, Keenan K, Ooi CY, Dorfman R, Sontag MK, Naehrlich L, Castellani C, Strug LJ, Rommens JM, Gonska T (2016) Prevalence of meconium ileus marks the severity of mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genet Med 18:333–340
Olszowiec-Chlebna M, Koniarek-Maniecka A, Stelmach W, Smejda K, Jerzynska J, Majak P, Bialas M, Stelmach I (2016) Predictors of deterioration of lung function in Polish children with cystic fibrosis. Arch Med Sci 12:402–407
Chiotis D, Krikos X, Tsiftis G, Hatzisymeaon M, Maniati-Christidi M, Dacou-Voutetaki A (2004) Body mass index and prevalence of obesity in subjects of Hellenic origin aged 0-18 years, living in the Athens area. Ann Clin Pediatr Unive Atheniensis 51:139–154
Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG Jr (1993) Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 15:75–88
Hankinson JL, Odencrantz JR, Fedan KB (1999) Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:179–187
Doulgeraki A, Skarpalezou A, Theodosiadou A, Monopolis I, Schulpis K (2014) Body composition profile of young patients with phenylketonuria and mild hyperphenylalaninemia. Int J Endocrinol Metab 12:e16061
Kalkwarf HJ, Abrams SA, DiMeglio LA, Koo WW, Specker BL, Weiler H; International Society for Clinical Densitometry (2014) Bone densitometry in infants and young children: the 2013 ISCD Pediatric Official Positions. J Clin Densitom 17:243–257
Proesmans M, Balinska-Miskiewicz W, Dupont L, Bossuyt X, Verhaegen J, Hoiby N, de Boeck K (2006) Evaluating the “Leeds criteria” for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Eur Respir J 27:937–943
Sermet-Gaudelus I, Bianchi ML, Garabedian M, Aris RM, Morton A, Hardin DS, Elkin SL, Compston JE, Conway SP, Castanet M, Wolfe S, Haworth CS (2011) European cystic fibrosis bone mineralisation guidelines. J Cyst Fibros 10(Suppl 2):S16–S23
Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, Hosking DJ, Purdie DW, Ralston SH, Reeve J, Russell RG, Stevenson JC, Torgerson DJ (1998) A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 244:271–292
Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, Kecskemethy HH, Jaworski M, Gordon CM; International Society for Clinical Densitometry (2014) Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J Clin Densitom 17:225–242
Putman MS, Baker JF, Uluer A, Herlyn K, Lapey A, Sicilian L, Tillotson AP, Gordon CM, Merkel PA, Finkelstein JS (2015) Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period. J Cyst Fibros 14:526–532
Lucidi V, Alghisi F, Raia V, Russo B, Valmarana L, Valmarana R, Coruzzo A, Beschi S, Dester S, Rinaldi D, Maglieri M, Guidotti ML, Ravaioli E, Pesola M, De Alessandri A, Padoan R, Grynzich L, Ratclif L, Repetto T, Ambroni M, Provenzano E, Tozzi AE, Colombo C (2009) Growth assessment of paediatric patients with CF comparing different auxologic indicators: a multicentre Italian study. J Pediatr Gastroenterol Nutr 49:335–342
Baker JF, Putman MS, Herlyn K, Tillotson AP, Finkelstein JS, Merkel PA (2016) Body composition, lung function, and prevalent and progressive bone deficits among adults with cystic fibrosis. Joint Bone Spine 83:207–211
Kerem E, Viviani L, Zolin A, MacNeill S, Hatziagorou E, Ellemunter H, Drevinek P, Gulmans V, Krivec U, Olesen H, Group EPRS (2014) Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry. Eur Respir J 43:125–133
Carlyle BE, Borowitz DS, Glick PL (2012) A review of pathophysiology and management of fetuses and neonates with meconium ileus for the pediatric surgeon. J Pediatr Surg 47:772–781
Li Z, Lai HJ, Kosorok MR, Laxova A, Rock MJ, Splaingard ML, Farrell PM (2004) Longitudinal pulmonary status of cystic fibrosis children with meconium ileus. Pediatr Pulmonol 38:277–284
Kappler M, Feilcke M, Schroter C, Kraxner A, Griese M (2009) Long-term pulmonary outcome after meconium ileus in cystic fibrosis. Pediatr Pulmonol 44:1201–1206
Johnson JA, Bush A, Buchdahl R (2010) Does presenting with meconium ileus affect the prognosis of children with cystic fibrosis? Pediatr Pulmonol 45:951–958
Kerem E, Corey M, Kerem B, Durie P, Tsui LC, Levison H (1989) Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr 114:767–773
Coutts JA, Docherty JG, Carachi R, Evans TJ (1997) Clinical course of patients with cystic fibrosis presenting with meconium ileus. Br J Surg 84:555
Vanacor R, Raimundo FV, Marcondes NA, Corte BP, Ascoli AM, Azambuja AZ, Scopel L, Santos PV, Dalcin PT, Faulhaber GA, Furlanetto TW (2014) Prevalence of low bone mineral density in adolescents and adults with cystic fibrosis. Rev Assoc Med Bras (1992) 60:53–58
Street ME, Spaggiari C, Ziveri MA, Volta C, Federico G, Baroncelli GI, Bernasconi S, Saggese G (2006) Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines. Horm Res 66:162–168
Frangolias DD, Pare PD, Kendler DL, Davidson AG, Wong L, Raboud J, Wilcox PG (2003) Role of exercise and nutrition status on bone mineral density in cystic fibrosis. J Cyst Fibros 2:163–170
Dassios T, Kaditis A, Katelari A, Chrousos G, Doudounakis S, Dimitriou G (2015) Time constant of inspiratory muscle relaxation in cystic fibrosis. Pediatr Res 77:541–545
Dassios TG, Katelari A, Doudounakis S, Dimitriou G (2014) Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis. Respir Care 59:363–370
Author information
Authors and Affiliations
Contributions
Artemis Doulgeraki: Dr. Doulgeraki participated in the preparation of the research proposal, contributed to data analysis, prepared the first draft of the manuscript, approved the final manuscript as submitted, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Argyri Petrocheilou: Dr. A. Petrocheilou reviewed the research proposal, contributed to clinical evaluation of the patients, critically reviewed and approved the final manuscript as submitted, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Glykeria Petrocheilou: Dr. G. Petrocheilou contributed to data analysis and interpretation, critically reviewed and approved the final manuscript as submitted, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
George Chrousos: Dr. Chrousos contributed to data analysis and interpretation, critically reviewed and approved the final manuscript as submitted, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Stavros-Eleftherios Doudounakis: Dr. Doudounakis reviewed the research proposal, contributed to clinical evaluation of the patients, critically reviewed and approved the final manuscript as submitted, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Athanasios Kaditis: Dr. Kaditis participated in the preparation of the research proposal, contributed to data analysis and data interpretation, prepared the final draft of the manuscript, approved the final manuscript as submitted, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Funding
There was no funding for the present work. There were no sources of funding or support.
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human participants
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
The current retrospective study was approved by the Aghia Sophia Children’s Hospital Scientific Council.
Additional information
Communicated by Peter de Winter
Electronic supplementary material
ESM 1
(PDF 139 kb)
Rights and permissions
About this article
Cite this article
Doulgeraki, A., Petrocheilou, A., Petrocheilou, G. et al. Body composition and lung function in children with cystic fibrosis and meconium ileus. Eur J Pediatr 176, 737–743 (2017). https://doi.org/10.1007/s00431-017-2906-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-017-2906-z